A new drug has ‘potentially very promising’ results for pancreatic cancer, scientists claim.
Mice with the disease were cured after being given medication that uses their immune cells to attack tumours, with similar treatment being effective in children with leukaemia.
Pancreatic cancer affects around one in 71 people in the UK and 1.6 per cent in the US at some point in their lives.
Only 20 per cent live a year after diagnosis and just seven per cent survive five years. This is due to pancreatic cancer usually only being diagnosed once it has spread as a result of its vague symptoms, such as weight loss and abdominal pain.
Actors Alan Rickman and Patrick Swayze, as well as Apple co-founder Steve Jobs, all lost their battles with the disease.
A new drug has ‘potentially very promising’ results for pancreatic cancer. The disease killed Harry Potter actor Alan Rickman on January 14 2016, six months after he was diagnosed
Apple co-founder Steve Jobs also passed away due to pancreatic cancer on October 5 2011. Jobs was diagnosed with a relatively unaggressive form of the disease eight years earlier
‘The news is that there is a potentially very promising therapy’
Study author Professor Nick Lemoine, from Barts Cancer Institute, told the Evening Standard: ‘We have achieved what appears to be cures in the animal models, but this still remains early days. So far, all the signals look really positive.
‘The news is that there is a potentially very promising therapy.’
The drug works by scientists taking immune cells, known as white blood cells, from mice and engineering them so they multiply before reinfusing them into the animals.
A virus is also put into the rodents that causes cancer to send out signals that make immune cells notice it.
The researchers hope the treatment could be trialed on human sufferers by 2020.
Pancreatic cancer UK has invested £500,000 into three years of research to double the disease’s five-year survival rate.
Dirty Dancing star Patrick Swayze died from pancreatic cancer that had spread to his liver on September 14 2009, 20 months after he was diagnosed when suffering abdominal pain
Cannabis drug may help pancreatic-cancer patients live almost three times longer
This comes after research released earlier this month suggested a supplement derived from cannabis could boost survival in pancreatic cancer patients by almost three times.
Mice with the condition live longer when they are given the marijuana compound cannabidiol (CBD) alongside a common chemotherapy drug, a UK study found today.
CBD does not contain any THC, which is the psychoactive component of cannabis that makes users ‘high’.
Previous research suggest cannabis treats cancer by stopping cell division, preventing tumours forming blood vessels and killing cancerous cells.
Speaking of the results, study author Professor Marco Falasca, from Queen Mary University of London, said: ‘This is a remarkable result.
‘The life expectancy for pancreatic cancer patients has barely changed in the last 40 years because there are very few, and mostly only palliative care, treatments available.’
Medical cannabis will available on prescription in the UK after it was approved by the Government last week.